Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China
- DOI
- 10.1136/bmjopen-2023-075138
- Published
- 2024-03
- Container
- BMJ Open
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2023-075138,
title = {Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China},
author = {Li Huang and Jun Zou and Yuxin Zhang and Jiaowei Gu and Jianlong Wu and Che Zhang},
year = {2024},
journal = {BMJ Open},
doi = {10.1136/bmjopen-2023-075138},
url = {https://doi.org/10.1136/bmjopen-2023-075138}
}RIS
TY - JOUR TI - Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China AU - Li Huang AU - Jun Zou AU - Yuxin Zhang AU - Jiaowei Gu AU - Jianlong Wu AU - Che Zhang PY - 2024 JO - BMJ Open DO - 10.1136/bmjopen-2023-075138 UR - https://doi.org/10.1136/bmjopen-2023-075138 ER -
APA
Huang, L., Zou, J., Zhang, Y., Gu, J., Wu, J., & Zhang, C. (2024). Human umbilical cord mesenchymal stem cell therapy for renal dysfunction in Alport syndrome: protocol for an open-label, single-arm trial in China. BMJ Open. https://doi.org/10.1136/bmjopen-2023-075138
Source records
- crossref · retrieved 2026-09-26T00:35:46.149Z